DUBLIN–(BUSINESS WIRE)–The “Transdermal Drug Delivery – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering.
The Transdermal Drug Delivery market worldwide is projected to grow by US$2.8 Billion, driven by a compounded growth of 7.2%.
Cardiovascular, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.1 Billion by the year 2025, Cardiovascular will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 8.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$130.8 Million to the region’s size and clout in the next 5 to 6 years. Over US$132.9 Million worth of projected demand in the region will come from the rest of the European markets.
In Japan, Cardiovascular will reach a market size of US$206.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.9% over the next couple of years and add approximately US$489.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific.
All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include:
- Antares Pharma, Inc.
- Bayer AG
- Durect Corporation
- Iontera, Inc.
- Janssen Pharmaceuticals, Inc.
- Nitto Denko Corporation
- Novartis AG
- Pantec Biosolutions AG
- Tesa Labtec GmbH
- Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/8b2k2e
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900